| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2013 | US20130030189 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 01/31/2013 | US20130030057 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
| 01/31/2013 | US20130030056 Methods of delivering pharmaceutical agents |
| 01/31/2013 | US20130030055 Compositions and methods for treating hair loss, hair thinning, and hair color loss |
| 01/31/2013 | US20130030054 Highly flavored ornithine-containing alcohol-free malt beverage |
| 01/31/2013 | US20130030053 Novel niddm regimen |
| 01/31/2013 | US20130030052 Compositions and methods for the sustained release of beta-alanine |
| 01/31/2013 | US20130030051 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
| 01/31/2013 | US20130030050 Treatment of osteoporosis |
| 01/31/2013 | US20130030049 Methods of treating dermatological disorders or conditions |
| 01/31/2013 | US20130030048 Composition for inducing multiple nuclear division of cells |
| 01/31/2013 | US20130030047 Fatty Acid Derivatives of Catechins and Methods of Their use |
| 01/31/2013 | US20130030046 Use of black soybean hull extracts in manufacture of products for preventing and treating osteoarthritis |
| 01/31/2013 | US20130030045 Method of preventing and treating osteoporosis |
| 01/31/2013 | US20130030044 New series of artemisinin derivatives and process for preparation thereof |
| 01/31/2013 | US20130030043 Treating glaucoma, cardiovascular diseases, and renal diseases |
| 01/31/2013 | US20130030042 Nucleic acids for targeting multiple regions of the hcv genome |
| 01/31/2013 | US20130030041 Near-infrared light-activated proteins |
| 01/31/2013 | US20130030039 Novel multidrug resistance-associated polypeptide |
| 01/31/2013 | US20130030038 Dermatological, Pharmaceutical Composition Suitable for Oligonucleotides |
| 01/31/2013 | US20130030037 RNAi Modulation Of RSV And Therapeutic Uses Thereof |
| 01/31/2013 | US20130030036 Modulation of forkhead box o1a expression |
| 01/31/2013 | US20130030035 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 01/31/2013 | US20130030034 Modulation of timp1 and timp2 expression |
| 01/31/2013 | US20130030033 4-trimethylammonio-butyrates as cpt2 inhibitors |
| 01/31/2013 | US20130030032 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/31/2013 | US20130030031 Novel Compounds |
| 01/31/2013 | US20130030030 Allantoin-containing skin cream |
| 01/31/2013 | US20130030029 Glucagon Antagonists |
| 01/31/2013 | US20130030028 Desferrithiocin polyether analogues |
| 01/31/2013 | US20130030027 Hemi-phorboxazole a derivatives and methods of their use |
| 01/31/2013 | US20130030026 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 01/31/2013 | US20130030025 Use of potassium channel blockers to treat cerebral palsy |
| 01/31/2013 | US20130030024 Method of Administering Pirfenidone Therapy |
| 01/31/2013 | US20130030023 Orally bioavailable dabigatran prodrugs for the treatment of diseases |
| 01/31/2013 | US20130030022 Compounds Which Selectively Modulate The CB2 Receptor |
| 01/31/2013 | US20130030021 Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and 1-Oxoisoindolines and Method of Reducing TNFalpha Levels |
| 01/31/2013 | US20130030020 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 01/31/2013 | US20130030019 Novel prolylcarboxypeptidase inhibitors |
| 01/31/2013 | US20130030018 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors |
| 01/31/2013 | US20130030017 Quinoline derivatives as antibacterial agents |
| 01/31/2013 | US20130030016 Quinoline derivatives as antibacterial agents |
| 01/31/2013 | US20130030015 Muscarinic acetylcholine receptor antagonists |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030013 Pharmaceutical preparation comprising phenylalanine derivative |
| 01/31/2013 | US20130030012 Compounds |
| 01/31/2013 | US20130030011 Compounds for the reduction of beta-amyloid production |
| 01/31/2013 | US20130030010 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/31/2013 | US20130030009 Method for the treatment and/or prevention of oral allergic symptions of the lips due to oral contact with a food allergen |
| 01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130030007 Obesity Small Molecules |
| 01/31/2013 | US20130030006 Agent for preventing or treating diseases accompanied by urinary pain |
| 01/31/2013 | US20130030005 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 01/31/2013 | US20130030004 Gyrase inhibitors and uses thereof |
| 01/31/2013 | US20130030003 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof |
| 01/31/2013 | US20130030001 Quinuclidine derivatives as muscarinic m3 receptor antagonists |
| 01/31/2013 | US20130030000 Pharmaceutical compositions for the treatment of pain and other indications |
| 01/31/2013 | US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/31/2013 | US20130029998 Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases |
| 01/31/2013 | US20130029997 Pyrazinoisoquinoline compounds |
| 01/31/2013 | US20130029996 Special composition for the use thereof as a drug |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029993 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors |
| 01/31/2013 | US20130029992 N,n-dialkylalkylenyl esters, compositions thereof, and methods for use thereof |
| 01/31/2013 | US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029989 Topical treatments for pain |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/31/2013 | US20130029986 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029984 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029983 Aminothienopyridazine inhibitors of tau assembly |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029980 Flavin derivatives |
| 01/31/2013 | US20130029979 Fused bicyclic compound |
| 01/31/2013 | US20130029978 Novel aryl urea derivative |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029975 Cgrp antagonists |
| 01/31/2013 | US20130029974 6,7-dihydroimidazo[1,5-a]pyrazin-8(5h)-one derivatives as protein kinase modulators |
| 01/31/2013 | US20130029973 Tetrahydrobenzothiophene compound |
| 01/31/2013 | US20130029972 Notch pathway signaling inhibitor compound |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029970 CB Receptor Agonists |
| 01/31/2013 | US20130029969 Heterocyclic compound |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029967 Fused Imidazo [3,2 - D] Pyrazines as P13 Kinase Inhibitors |
| 01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 01/31/2013 | US20130029965 Pharmaceutical solid dispersions |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029960 Enhanced bone healing |
| 01/31/2013 | US20130029959 Compositions and methods for the treatment of cancer |
| 01/31/2013 | US20130029958 Synthetic bile acid compositions and methods |
| 01/31/2013 | US20130029957 17-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods |
| 01/31/2013 | US20130029956 New method |